Diabetes
Patients with DME achieve long-term clinical improvement with intravitreal aflibercept
Patients with diabetic macular edema treated with intravitreal aflibercept for up to 24 months achieved functional and anatomical improvements, even with reduced injection frequency, according to study results in Ophthalmology and Therapy.
CGM use less likely for children with type 1 diabetes living in rural vs. urban areas
Children with type 1 diabetes living in small or isolated rural towns are less likely to use continuous glucose monitoring than those living in urban areas, according to data published in Diabetes Care.
VIDEO: Intervention could reduce economic burden, uncontrolled gout in US adults with CKD
PHILADELPHIA — Gout prevalence in U.S. adults with chronic kidney disease is expected to markedly increase during the next 12 years, suggests data presented at ASN Kidney Week.
Top in endocrinology: Tirzepatide for obesity treatment; successes in time-restricted eating
The FDA has recently approved injectable tirzepatide for chronic weight management in adults with overweight or obesity and at least one weight-related condition, such as high BP, type 2 diabetes or higher cholesterol.
CDC launches new public service announcements as part of prediabetes awareness initiative
The CDC has announced the launch of new public service announcements as part of its ongoing “Do I Have Prediabetes?” initiative to encourage people to learn about prediabetes diagnosis and risks.
SGLT2 inhibitors ‘substantially’ reduce gout risk in patients with type 2 diabetes
SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.
Type 2 diabetes associated with higher risk for colorectal cancer
Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.
VIDEO: Deepak L. Bhatt, MD, MPH, highlights new data on semaglutide, tirzepatide at AHA
PHILADELPHIA — In this Healio exclusive, Deepak L. Bhatt, MD, MPH, provides his perspective on research presented at the American Heart Association Scientific Sessions.
Regular marijuana use linked to risk for HF, major adverse heart, brain events
PHILADELPHIA — Two observational studies presented at the American Heart Association Scientific Sessions linked regular marijuana use to elevated risk for HF and elevated risk for major adverse cardiac and cerebrovascular events.
In acute MI, dapagliflozin confers cardiometabolic benefit, in absence of diabetes, HF
PHILADELPHIA — In patients without diabetes or heart failure presenting with acute MI and impaired left ventricular function, dapagliflozin improved cardiometabolic outcomes compared with placebo, according to the DAPA-MI trial.